NCT03432871 - Nicotinamide Riboside and Mitochondrial Biogenesis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 8, 2017

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2022

Conditions

Mitochondrial DiseasesMitochondrial MyopathiesProgressive External OphthalmoplegiaProgressive OphthalmoplegiaProgressive; Ophthalmoplegia, ExternalMitochondria DNA DeletionMELAS

Interventions

DIETARY_SUPPLEMENT

Nicotinamide Riboside

Nicotinamide Riboside is a member of the Vitamin B family which acts as a precursor to NAD+, an enzyme involved in energy production.

Trial Locations (1)

CB20QQ

Cambridge University Hospitals NHS Foundation Trust, Cambridge

All Listed Sponsors

collaborator

University of Cambridge

OTHER

collaborator

Medical Research Council Mitochondrial Biology Unit

UNKNOWN

lead

Cambridge University Hospitals NHS Foundation Trust

OTHER